Literature DB >> 21540015

No end in sight: the skin cancer epidemic continues.

Matthew R Donaldson1, Brett M Coldiron.   

Abstract

The incidence of nonmelanoma skin cancer (NMSC) continues to increase. Multiple reports from the United States and Europe suggest we are in the midst of an epidemic. European studies show substantial NMSC incidence increases during the last 2 decades. In the United States, a recent analysis of Medicare Claims data showed that procedures performed for NMSC nearly doubled from 1994 to 2006. From these data, the total number of new NMSC in 2006 was estimated to be 3,507,693. Procedure data for 2006-2008 from the 5% Medicare Claims sample dataset corroborate the reported trajectory of incidence increase. Destructions, excisions, and Mohs procedures for NMSC have increased by 2.6% per year during the last 2 years. On the basis of this current rate of increase, the annual incidence of NMSC in the United States in 2008 would be nearly 3.69 million. Recognizing the NMSC epidemic is critical as the incidence-and cost-will continue to increase. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21540015     DOI: 10.1016/j.sder.2011.01.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  40 in total

1.  Wireless, battery-free, flexible, miniaturized dosimeters monitor exposure to solar radiation and to light for phototherapy.

Authors:  Seung Yun Heo; Jeonghyun Kim; Philipp Gutruf; Anthony Banks; Pinghung Wei; Rafal Pielak; Guive Balooch; Yunzhou Shi; Hitoshi Araki; Derrick Rollo; Carey Gaede; Manish Patel; Jean Won Kwak; Amnahir E Peña-Alcántara; Kyu-Tae Lee; Yeojeong Yun; June K Robinson; Shuai Xu; John A Rogers
Journal:  Sci Transl Med       Date:  2018-12-05       Impact factor: 17.956

2.  Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancer.

Authors:  Jing Jiao; Tomo-O Ishikawa; Darren S Dumlao; Paul C Norris; Clara E Magyar; Carol Mikulec; Art Catapang; Edward A Dennis; Susan M Fischer; Harvey R Herschman
Journal:  Mol Cancer Res       Date:  2014-07-25       Impact factor: 5.852

3.  Implementation of fluorescence confocal mosaicking microscopy by "early adopter" Mohs surgeons and dermatologists: recent progress.

Authors:  Manu Jain; Milind Rajadhyaksha; Kishwer Nehal
Journal:  J Biomed Opt       Date:  2017-02-01       Impact factor: 3.170

Review 4.  UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.

Authors:  Gerd P Pfeifer; Ahmad Besaratinia
Journal:  Photochem Photobiol Sci       Date:  2011-08-01       Impact factor: 3.982

5.  Comparison of Dermatologist Density Between Urban and Rural Counties in the United States.

Authors:  Hao Feng; Juliana Berk-Krauss; Paula W Feng; Jennifer A Stein
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

Review 6.  Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.

Authors:  Edward V Maytin; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2020-04-15       Impact factor: 3.421

7.  Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude.

Authors:  Miguel Rivas; Elisa Rojas; Gloria M Calaf; Marcela Barberán; Claudio Liberman; Marcelo De Paula Correa
Journal:  Oncol Lett       Date:  2017-03-23       Impact factor: 2.967

8.  Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience.

Authors:  Eileen S Flores; Miguel Cordova; Kivanc Kose; William Phillips; Anthony Rossi; Kishwer Nehal; Milind Rajadhyaksha
Journal:  J Biomed Opt       Date:  2015-06       Impact factor: 3.170

9.  Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma.

Authors:  Sanjay Anand; Kishore R Rollakanti; Ronald L Horst; Tayyaba Hasan; Edward V Maytin
Journal:  Photochem Photobiol       Date:  2014-05-26       Impact factor: 3.421

10.  Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation.

Authors:  Huei-Chen Lao; Jacqueline K Akunda; Kyung-Soo Chun; Gordon P Flake; Stuart H Yuspa; Robert Langenbach
Journal:  Carcinogenesis       Date:  2012-08-17       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.